<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Lung transplantation: Preanesthetic consultation and preparation</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Lung transplantation: Preanesthetic consultation and preparation</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Lung transplantation: Preanesthetic consultation and preparation</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Rebecca M Gerlach, MD, FRCPC</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Michael F O'Connor, MD, FCCM</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jonathan B Mark, MD</a></dd><dt><span> </span>Deputy Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Nancy A Nussmeier, MD, FAHA</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Paul Dieffenbach, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Oct 17, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H2611775312"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Over 4000 lung transplants are performed annually worldwide after increasing steadily for the past decade  (<a class="graphic graphic_figure graphicRef71574" href="/z/d/graphic/71574.html" rel="external">figure 1</a>). This topic will discuss the preanesthetic consultation and preparations for lung transplantation.</p><p>Guidelines for selection of recipients are discussed in separate topics. (See  <a class="medical medical_review" href="/z/d/html/4659.html" rel="external">"Lung transplantation: An overview"</a> and  <a class="medical medical_review" href="/z/d/html/4658.html" rel="external">"Lung transplantation: General guidelines for recipient selection"</a>.)</p><p>Perioperative anesthetic management, surgical techniques, and postoperative management after lung transplantation are discussed in separate topics. (See  <a class="medical medical_review" href="/z/d/html/118937.html" rel="external">"Lung transplantation: Anesthetic management"</a> and  <a class="medical medical_review" href="/z/d/html/4660.html" rel="external">"Lung transplantation: Disease-based choice of procedure"</a> and  <a class="medical medical_review" href="/z/d/html/4651.html" rel="external">"Lung transplantation: Procedure and postoperative management"</a>.)</p><p class="headingAnchor" id="H2168046479"><span class="h1">PREANESTHETIC CONSULTATION</span></p><p class="headingAnchor" id="H3100354073"><span class="h2">Preoperative assessment and communication</span><span class="headingEndMark"> — </span>Anesthetic management of a patient undergoing lung transplantation is influenced by the planned surgical approach, urgency of the procedure (eg, need for preoperative extracorporeal membrane oxygenation [ECMO]), the patient's preoperative pulmonary status, and clinically significant comorbidities. Some transplant centers find it helpful to have a checklist for preoperative review  (<a class="graphic graphic_table graphicRef106946" href="/z/d/graphic/106946.html" rel="external">table 1</a>).</p><p class="headingAnchor" id="H3887274621"><span class="h3">Assessment of pulmonary status</span><span class="headingEndMark"> — </span>Preoperative assessment of pulmonary status focuses on the etiology of respiratory failure and preoperative oxygen requirements [<a href="#rid1">1</a>], as well as the presence of pulmonary hypertension [<a href="#rid2">2</a>]. Patients deemed at risk for cardiopulmonary collapse during induction of anesthesia should be identified in the preoperative period [<a href="#rid2">2,3</a>].</p><p>Since patients may be on a waitlist for many months prior to receiving an organ, it is important to identify any recent changes in pulmonary status that might impact eligibility for transplantation (eg, untreated or uncontrolled pulmonary infection). Interval COVID-19 infection is discussed below. (See <a class="local">'Considerations during the COVID-19 pandemic'</a> below.)</p><p>Intraoperative management of patients who require high levels of oxygen (&gt;4 L per minute) or airway secretion clearance therapy at home, and those with elevated baseline arterial partial pressure of carbon dioxide (PaCO<sub>2</sub>) on arterial blood gases or elevated pulmonary artery pressure (PAP), will be challenging. For patients who have suffered acute deterioration of pulmonary status, preoperative or intraoperative initiation of venovenous (VV) ECMO as a bridge to urgent transplantation may be planned [<a href="#rid4">4</a>]. Management of such intraoperative cardiorespiratory support is discussed in advance with the surgical team. (See  <a class="medical medical_review" href="/z/d/html/4658.html" rel="external">"Lung transplantation: General guidelines for recipient selection", section on 'Ventilator dependence and extracorporeal life support'</a> and  <a class="medical medical_review" href="/z/d/html/4651.html" rel="external">"Lung transplantation: Procedure and postoperative management", section on 'Extracorporeal life support'</a> and <a class="local">'Preoperative extracorporeal membrane oxygenation'</a> below.)</p><p class="headingAnchor" id="H661663762"><span class="h3">Assessment of comorbidities</span><span class="headingEndMark"> — </span>A number of comorbid conditions can affect lung transplant outcomes (see  <a class="medical medical_review" href="/z/d/html/4658.html" rel="external">"Lung transplantation: General guidelines for recipient selection"</a>) [<a href="#rid5">5</a>]. These are generally addressed prior to listing for lung transplant. Preanesthetic review involves determining whether the status of comorbidities has changed since the most recent review.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Anemia</strong> – It is important to treat anemia preoperatively when feasible [<a href="#rid1">1</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Frailty</strong> – Also, frailty related to age or chronic end-organ disease is typically identified and treated if possible (eg, physical rehabilitation, nutritional optimization) [<a href="#rid6">6</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cardiovascular</strong> – Evaluation of cardiovascular status is typically accomplished with echocardiography, which is typically repeated every three to six months to assess right (and left) ventricular function in lung transplantation candidates; right heart catheterization is performed less frequently. In rare cases, results of these studies may determine that the patient is a candidate for heart-lung transplantation rather than lung transplantation. (See <a class="local">'Need for heart-lung transplantation'</a> below and  <a class="medical medical_review" href="/z/d/html/4660.html" rel="external">"Lung transplantation: Disease-based choice of procedure", section on 'Heart-lung transplantation'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Other organ systems </strong>–<strong> </strong>Many diseases that result in end-stage lung pathology<strong> </strong>requiring lung transplantation are systemic diseases that affect other organs. Examples include:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Cystic fibrosis is a multisystem disease that can cause end-stage lung disease, as well as hepatobiliary disease, pancreatic disease, and gastrointestinal manifestations that should be evaluated in the preoperative assessment [<a href="#rid7">7</a>]. (See  <a class="medical medical_review" href="/z/d/html/5858.html" rel="external">"Cystic fibrosis: Overview of gastrointestinal disease"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Pulmonary fibrosis resulting from rheumatologic diseases such as systemic sclerosis (scleroderma) or polymyositis typically has systemic manifestations including chronic kidney disease, cirrhosis, pulmonary hypertension, airway abnormalities (systemic sclerosis), or muscular abnormalities resulting in abnormal response to neuromuscular blocking agents (polymyositis). (See  <a class="medical medical_review" href="/z/d/html/7539.html" rel="external">"Clinical manifestations and diagnosis of systemic sclerosis (scleroderma) in adults"</a> and  <a class="medical medical_review" href="/z/d/html/5159.html" rel="external">"Clinical manifestations of dermatomyositis and polymyositis in adults"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Pulmonary fibrosis resulting from telomerase mutations may result in thrombocytopenia from bone marrow suppression, cirrhosis, or enteropathies [<a href="#rid8">8</a>]. (See  <a class="medical medical_review" href="/z/d/html/100663.html" rel="external">"Dyskeratosis congenita and other telomere biology disorders"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Sarcoidosis is a multisystem disease that predominantly affects the lung parenchyma and mediastinal lymph nodes, but may also lead to pulmonary hypertension, restrictive cardiomyopathy, cardiac arrhythmias, kidney dysfunction, hepatic disease, and neurologic symptoms. (See  <a class="medical medical_review" href="/z/d/html/4353.html" rel="external">"Clinical manifestations and diagnosis of sarcoidosis"</a> and  <a class="medical medical_review" href="/z/d/html/91259.html" rel="external">"Overview of extrapulmonary manifestations of sarcoidosis"</a> and  <a class="medical medical_review" href="/z/d/html/4922.html" rel="external">"Clinical manifestations and diagnosis of cardiac sarcoidosis"</a>.)</p><p></p><p>Any severe comorbidities that may affect the candidate's suitability for transplantation are discussed with the lung transplantation medical and surgical teams. (See  <a class="medical medical_review" href="/z/d/html/4658.html" rel="external">"Lung transplantation: General guidelines for recipient selection"</a>.)</p><p class="headingAnchor" id="H995695148"><span class="h3">Risk for allosensitization</span><span class="headingEndMark"> — </span>Possible allosensitization is assessed by the lung transplantation team. Current and historical human leukocyte antigen (HLA) antibody screening tests and the specificity of any pre-formed HLA antibodies should be reviewed. (See  <a class="medical medical_review" href="/z/d/html/4658.html" rel="external">"Lung transplantation: General guidelines for recipient selection", section on 'Allosensitization'</a> and <a class="local">'Crossmatching for blood products'</a> below and  <a class="medical medical_review" href="/z/d/html/16926.html" rel="external">"Evaluation and treatment of antibody-mediated lung transplant rejection", section on 'Laboratory'</a>.)</p><p class="headingAnchor" id="H674465514"><span class="h3">Communication regarding planned surgical approach</span><span class="headingEndMark"> — </span>The surgeon and lung transplantation team determine whether the patient will have a single lung transplant, bilateral lung transplant, or heart-lung transplantation based on underlying disease [<a href="#rid9">9</a>]. The incision may be a transverse thoracosternotomy also known as a clamshell incision  (<a class="graphic graphic_figure graphicRef90511" href="/z/d/graphic/90511.html" rel="external">figure 2</a>), unilateral or bilateral anterolateral thoracotomy  (<a class="graphic graphic_figure graphicRef86029" href="/z/d/graphic/86029.html" rel="external">figure 3</a>), or median sternotomy (which requires full cardiopulmonary bypass [CPB])  (<a class="graphic graphic_figure graphicRef86046" href="/z/d/graphic/86046.html" rel="external">figure 4</a>). For single lung transplant, the side to be transplanted should be clearly marked.</p><p>These decisions influence anesthetic management, as discussed separately:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/118937.html" rel="external">"Lung transplantation: Anesthetic management", section on 'Overview of surgical techniques'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/4660.html" rel="external">"Lung transplantation: Disease-based choice of procedure"</a>.)</p><p></p><p>In addition, plans for preoperative or intraoperative use of mechanical respiratory or circulatory support influence anesthetic management:</p><p class="bulletIndent1"><span class="glyph">●</span>(See <a class="local">'Preoperative extracorporeal membrane oxygenation'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/118937.html" rel="external">"Lung transplantation: Anesthetic management", section on 'Mechanical cardiorespiratory support'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/4651.html" rel="external">"Lung transplantation: Procedure and postoperative management", section on 'Extracorporeal life support'</a>.)</p><p></p><p class="headingAnchor" id="H573242839"><span class="h2">Crossmatching for blood products</span><span class="headingEndMark"> — </span>We crossmatch four units of packed red blood cells (RBCs) and four units of fresh frozen plasma (FFP) for bilateral lung transplantation or single lung transplantation with planned mechanical cardiorespiratory support, either CPB or intraoperative ECMO.</p><p>For single lung transplant surgery without cardiorespiratory support, two units of packed RBCs are typically sufficient.</p><p>Pretransfusion testing is required before surgery in order to have compatible blood products available for transfusion once the patient is in the operating room and ready for anesthetic induction. (See <a class="local">'Planning timing of anesthetic induction'</a> below and  <a class="medical medical_review" href="/z/d/html/7953.html" rel="external">"Pretransfusion testing for red blood cell transfusion"</a>.)</p><p>Although use of perioperative blood transfusion during lung transplantation has decreased over the last few decades, up to 70 percent of lung transplant recipients receive at least one RBC unit within 24 hours of surgery [<a href="#rid10">10,11</a>]. Approximately one-quarter of patients may need massive transfusion (defined &gt;10 units of RBCs within 24 hours) [<a href="#rid10">10</a>].<strong> </strong>Patient-related factors for increased transfusion risk include cystic fibrosis, pulmonary hypertension, Eisenmenger syndrome, and low body mass index (BMI), while procedure-related factors include requirement for mechanical circulatory support, bilateral transplantation, or retransplantation procedures [<a href="#rid1">1,10</a>].</p><p class="headingAnchor" id="H643853533"><span class="h2">Preoperative medication management</span></p><p class="headingAnchor" id="H84350922"><span class="h3">Chronically administered medications</span><span class="headingEndMark"> — </span>General considerations for management of chronically administered medications are discussed in a separate topic. (See  <a class="medical medical_review" href="/z/d/html/4814.html" rel="external">"Perioperative medication management"</a>.)</p><p>Many lung transplant recipients have chronic obstructive pulmonary disease and receive chronic bronchodilator therapy, which is continued in the preoperative period at the usual doses up to the time of surgery. For single lung recipients, these medications are continued after surgery, but can usually be discontinued after bilateral lung transfusion. Some patients may need additional doses of short-acting inhaled bronchodilators in the perioperative period. (See  <a class="medical medical_review" href="/z/d/html/94354.html" rel="external">"Anesthesia for patients with chronic obstructive pulmonary disease", section on 'Inhaled bronchodilators and glucocorticoids'</a>.)</p><p>For recipients with pulmonary arterial hypertension (PAH), it is critically important to continue throughout the perioperative period all chronically administered medications that are prescribed for pulmonary hypertension. Patients with type 1 PAH are typically receiving parental, oral, and inhaled PAH-targeted therapies  (<a class="graphic graphic_table graphicRef50798" href="/z/d/graphic/50798.html" rel="external">table 2</a>), which should be continued without interruption until CPB is initiated.</p><p>These PAH-targeted agents include:</p><p class="bulletIndent1"><span class="glyph">●</span>Prostacyclin pathway agonists (eg, <a class="drug drug_general" data-topicid="9411" href="/z/d/drug information/9411.html" rel="external">epoprostenol</a>, <a class="drug drug_general" data-topicid="10207" href="/z/d/drug information/10207.html" rel="external">treprostinil</a>, <a class="drug drug_general" data-topicid="8895" href="/z/d/drug information/8895.html" rel="external">iloprost</a>, <a class="drug drug_general" data-topicid="106041" href="/z/d/drug information/106041.html" rel="external">selexipag</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Endothelin receptor antagonists (eg, <a class="drug drug_general" data-topicid="9254" href="/z/d/drug information/9254.html" rel="external">bosentan</a>, <a class="drug drug_general" data-topicid="91206" href="/z/d/drug information/91206.html" rel="external">macitentan</a>, <a class="drug drug_general" data-topicid="8653" href="/z/d/drug information/8653.html" rel="external">ambrisentan</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Nitric oxide-cyclic guanosine monophosphate enhancers (eg, the phosphodiesterase-5 inhibitors <a class="drug drug_general" data-topicid="9643" href="/z/d/drug information/9643.html" rel="external">sildenafil</a> and <a class="drug drug_general" data-topicid="10108" href="/z/d/drug information/10108.html" rel="external">tadalafil</a>, or the guanylate cyclase activator <a class="drug drug_general" data-topicid="91067" href="/z/d/drug information/91067.html" rel="external">riociguat</a>).</p><p></p><p>Inhaled nitric oxide (iNO) may be used in addition or as a substitute for these medications during the perioperative period.</p><p>Notably, PAH-targeted therapies, particularly prostacyclin pathway agonists (eg, <a class="drug drug_general" data-topicid="9411" href="/z/d/drug information/9411.html" rel="external">epoprostenol</a>, <a class="drug drug_general" data-topicid="10207" href="/z/d/drug information/10207.html" rel="external">treprostinil</a>, <a class="drug drug_general" data-topicid="8895" href="/z/d/drug information/8895.html" rel="external">iloprost</a>, <a class="drug drug_general" data-topicid="106041" href="/z/d/drug information/106041.html" rel="external">selexipag</a>) can also cause systemic vasodilation and exacerbate intraoperative hypotension. Treatment with <a class="drug drug_general" data-topicid="9709" href="/z/d/drug information/9709.html" rel="external">norepinephrine</a> and/or <a class="drug drug_general" data-topicid="10039" href="/z/d/drug information/10039.html" rel="external">vasopressin</a> infusion is typically necessary to maintain systemic vascular resistance and blood pressure  (<a class="graphic graphic_table graphicRef119747" href="/z/d/graphic/119747.html" rel="external">table 3</a>).</p><p>After reperfusion of the lung allograft(s), these targeted therapies for PAH can usually be tapered and discontinued. (See  <a class="medical medical_review" href="/z/d/html/94362.html" rel="external">"Anesthesia for noncardiac surgery in patients with pulmonary hypertension or right heart failure", section on 'Management of chronic medications'</a> and  <a class="medical medical_review" href="/z/d/html/118937.html" rel="external">"Lung transplantation: Anesthetic management", section on 'Hemodynamic management'</a>.)</p><p class="headingAnchor" id="H1419749165"><span class="h3">Premedication</span><span class="headingEndMark"> — </span>Any preoperative sedative is cautiously administered in small doses, with continuous monitoring of oxygenation and blood pressure. Lung transplant recipients typically have chronic hypercapnia and are very susceptible to respiratory depression. Development of hypoxemia or more importantly hypercarbia due to respiratory depression increases pulmonary vascular resistance (PVR) and worsens pre-existing pulmonary hypertension and right ventricular (RV) dysfunction. (See  <a class="medical medical_review" href="/z/d/html/94354.html" rel="external">"Anesthesia for patients with chronic obstructive pulmonary disease", section on 'Premedication'</a>.)</p><p class="headingAnchor" id="H444358588"><span class="h2">Planning for postoperative analgesia</span><span class="headingEndMark"> — </span>At our center, we usually use thoracic epidural analgesia (TEA) for postoperative pain control and place the catheter after reversal of anticoagulation. This generally occurs in the intensive care unit to facilitate tracheal extubation. However, the optimal approach to postoperative analgesia has not been determined and randomized trials have not been performed.</p><p>Pain following unilateral or bilateral transverse thoracotomy necessitates planning for postoperative analgesia (see  <a class="medical medical_review" href="/z/d/html/94261.html" rel="external">"Anesthesia for open pulmonary resection", section on 'Post-thoracotomy pain management'</a>), and pain after transverse thoracosternotomy (ie, clamshell) incision is particularly severe. No consensus exists regarding the optimal approach to analgesia, and no randomized trials examining this question have been performed [<a href="#rid12">12</a>]. (See  <a class="medical medical_review" href="/z/d/html/118937.html" rel="external">"Lung transplantation: Anesthetic management", section on 'Postoperative analgesia'</a>.)</p><p>Placement of a catheter for TEA is employed in many centers to reduce the amount of systemic opioid needed for analgesia [<a href="#rid12">12-16</a>]. Placement of a continuous paravertebral block (PVB) catheter is an alternative technique to provide postoperative analgesia after thoracotomy [<a href="#rid17">17-19</a>]. Since PVB is a deep block in a noncompressible space, considerations for timing of catheter placement are similar to those for an epidural in patients receiving anticoagulants. Although the incidence of hemorrhagic complications after PVB is unknown, case reports have described this complication. (See  <a class="medical medical_review" href="/z/d/html/14930.html" rel="external">"Neuraxial anesthesia/analgesia techniques in the patient receiving anticoagulant or antiplatelet medication"</a>.)</p><p>Considerations for timing of TEA or PVB catheter placement include the risk of epidural hematoma, particularly if systemic heparinization for preoperative or intraoperative ECMO or use of CPB is planned:</p><p class="bulletIndent1"><span class="glyph">●</span>(See <a class="local">'Preoperative extracorporeal membrane oxygenation'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/118937.html" rel="external">"Lung transplantation: Anesthetic management", section on 'Intraoperative venovenous (VV) ECMO support'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/118937.html" rel="external">"Lung transplantation: Anesthetic management", section on 'Intraoperative venoarterial ECMO support'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/118937.html" rel="external">"Lung transplantation: Anesthetic management", section on 'Use of cardiopulmonary bypass'</a>.)</p><p></p><p>Thus, in many centers, including ours, postoperative placement of epidural or paravertebral catheters is preferred because the risk of systemic anticoagulation is no longer present [<a href="#rid14">14</a>]. However, institutional preferences and protocols vary, and discussion with the surgical team regarding the planned incision(s), possible need for intraoperative systemic anticoagulation, and likelihood of postoperative mechanical cardiorespiratory support requiring systemic anticoagulation is important. (See  <a class="medical medical_review" href="/z/d/html/118937.html" rel="external">"Lung transplantation: Anesthetic management", section on 'Thoracic epidural analgesia'</a>.)</p><p>If an epidural catheter or bilateral PVB catheters are placed in the preoperative period, intraoperative administration of local anesthetic is typically avoided as this may result in a sympathectomy with vasodilation and hypotension, thereby making it difficult to maintain a restrictive fluid management strategy (see  <a class="medical medical_review" href="/z/d/html/118937.html" rel="external">"Lung transplantation: Anesthetic management", section on 'Fluid and transfusion management'</a>). Thus, initiation of a local anesthetic infusion is generally deferred until the surgical procedure has been completed. (See  <a class="medical medical_review" href="/z/d/html/118937.html" rel="external">"Lung transplantation: Anesthetic management", section on 'Postoperative analgesia'</a>.)</p><p class="headingAnchor" id="H1244228165"><span class="h2">Determination of fasting status</span><span class="headingEndMark"> — </span>Since lung transplant recipients receive notification of a potential matched donor lung within hours of receiving the organ, preoperative fasting may be inadequate to allow for stomach emptying. A transplant is not elective and cannot be postponed since organ ischemic time is ideally minimized to less than six hours to avoid graft dysfunction that is more likely with longer ischemic times. (See  <a class="medical medical_review" href="/z/d/html/4652.html" rel="external">"Lung transplantation: Donor lung procurement and preservation", section on 'Steps to optimize lung preservation'</a>.)</p><p>If there is inadequate time to adhere to fasting guidelines  (<a class="graphic graphic_table graphicRef94641" href="/z/d/graphic/94641.html" rel="external">table 4</a>), rapid sequence induction of anesthesia is performed, with appropriate additional precautions against aspiration, as described separately. (See  <a class="medical medical_review" href="/z/d/html/15698.html" rel="external">"Preoperative fasting in adults"</a> and  <a class="medical medical_review" href="/z/d/html/94214.html" rel="external">"Rapid sequence induction and intubation (RSII) for anesthesia"</a>.)</p><p class="headingAnchor" id="H2854284631"><span class="h2">Planning timing of anesthetic induction</span><span class="headingEndMark"> — </span>Perioperative preparation of the transplant recipient and induction of anesthesia are carefully coordinated with donor lung procurement to minimize the time from resection to implantation (ie, cold ischemic time). The recipient proceeds to the operating room after the donor lungs are initially assessed and determined to be of sufficient quality to be suitable for transplantation. During the preoperative period, regular communication between the anesthesiologist and the surgeon or transplant coordinator ensures optimal timing for induction of anesthesia. However, the organ procurement team will make a final determination regarding whether the donor lungs are of sufficient quality to proceed with transplantation only after direct physical examination of the lungs on-site. (See  <a class="medical medical_review" href="/z/d/html/4651.html" rel="external">"Lung transplantation: Procedure and postoperative management", section on 'Preparation'</a>.)</p><p>Cold ischemic time begins when the donor pulmonary artery supplying the lung is cross-clamped, and ends at reperfusion after implantation in the recipient. Following removal from the donor, lungs are flushed with cold preservation solution, partially inflated, and chilled for transport. Depending on the travel distance from donor to recipient sites, final determination of allograft quality may occur after induction of anesthesia in the proposed recipient. Thus, preoperative discussion with the patient and family regarding final inspection of donor lungs and possible cancellation of the procedure is necessary to set realistic expectations. If the donor lungs do not meet criteria, the procedure is aborted, and the anesthesiology team is notified that the transplant has been cancelled.</p><p>The details of donor lung procurement and preservation are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/4652.html" rel="external">"Lung transplantation: Donor lung procurement and preservation", section on 'Steps to optimize lung preservation'</a> and  <a class="medical medical_review" href="/z/d/html/4652.html" rel="external">"Lung transplantation: Donor lung procurement and preservation", section on 'Normothermic ex-vivo perfusion (after cold static preservation)'</a>.)</p><p class="headingAnchor" id="H3514937571"><span class="h1">SPECIAL SITUATIONS</span></p><p class="headingAnchor" id="H2756930005"><span class="h2">Preoperative extracorporeal membrane oxygenation</span><span class="headingEndMark"> — </span>Patients with hypoxic or hypercapnic respiratory failure (eg, partial pressure of oxygen [PaO<sub>2</sub>] &lt;60 mmHg, partial pressure of carbon dioxide [PaCO<sub>2</sub>] &gt;60 mmHg, pH &lt;7.20) may benefit from preoperative initiation of venovenous (VV) extracorporeal membrane oxygenation (ECMO) as a bridge to transplantation  (<a class="graphic graphic_figure graphicRef56622" href="/z/d/graphic/56622.html" rel="external">figure 5</a> and <a class="graphic graphic_diagnosticimage graphicRef116518" href="/z/d/graphic/116518.html" rel="external">image 1</a>) [<a href="#rid20">20-28</a>]. Avoiding femoral cannulation by placing a dual-lumen right internal jugular cannula allows for active rehabilitation with ambulation during ECMO support, thereby avoiding deconditioning in patients who are hemodynamically stable and extubated (or breathing spontaneously through a tracheostomy) while awaiting transplantation surgery [<a href="#rid29">29,30</a>]. (See  <a class="medical medical_review" href="/z/d/html/1625.html" rel="external">"Extracorporeal life support in adults in the intensive care unit: Overview"</a> and  <a class="medical medical_review" href="/z/d/html/4651.html" rel="external">"Lung transplantation: Procedure and postoperative management", section on 'Extracorporeal life support'</a>.)</p><p>Much less commonly, a patient may be bridged to transplant with venoarterial (VA) ECMO in the setting of pulmonary arterial hypertension (PAH) and concomitant right ventricular (RV) dysfunction [<a href="#rid28">28</a>]. Although RV function often improves with the reduction in pulmonary vascular resistance (PVR) that occurs after reperfusion of transplanted lungs, assessment of preoperative RV function is necessary to plan likely intraoperative and postoperative pharmacologic and mechanical RV support. The latter option includes either continuing VA ECMO or transitioning to a RV assist device at the conclusion of surgery. Notably, patients with longstanding severe RV failure may not be candidates for lung transplantation alone, but may require a combined heart-lung transplantation.</p><p>If ECMO is to be initiated, the anesthesiology team typically provides assistance to accomplish insertion of the necessary cannulae using transesophageal echocardiography [<a href="#rid28">28</a>] as described in detail in a separate topic. (See  <a class="medical medical_review" href="/z/d/html/131002.html" rel="external">"Extracorporeal life support in adults in the intensive care unit: The role of transesophageal echocardiography (TEE)"</a>.)</p><p>Some patients who did not require support in the preoperative period may need to have VV ECMO established electively or urgently during the intraoperative period, as discussed separately (see  <a class="medical medical_review" href="/z/d/html/118937.html" rel="external">"Lung transplantation: Anesthetic management", section on 'Intraoperative venovenous (VV) ECMO support'</a>) [<a href="#rid1">1,28</a>]. Once initiated, support is typically maintained throughout the transplantation procedure. Intraoperative conversion to VA ECMO or to full cardiopulmonary bypass (CPB) may be necessary in patients with severe PAH [<a href="#rid23">23,28</a>]. (See  <a class="medical medical_review" href="/z/d/html/118937.html" rel="external">"Lung transplantation: Anesthetic management", section on 'Intraoperative venoarterial ECMO support'</a>.)</p><p class="headingAnchor" id="H4008464579"><span class="h2">Need for heart-lung transplantation</span><span class="headingEndMark"> — </span>In rare circumstances, combined heart-lung transplantation may be performed in a patient with both end-stage heart failure and end-stage lung disease refractory to medical therapy, usually due to PAH refractory to treatment and concomitant severe RV failure. Examples include patients with Eisenmenger syndrome or idiopathic PAH [<a href="#rid31">31</a>]. Only 51 heart-lung transplants were performed in the United States in 2022 [<a href="#rid32">32</a>]. Considerations affecting anesthetic management are discussed below, while general considerations for heart-lung transplantation are discussed in a separate topic. (See  <a class="medical medical_review" href="/z/d/html/3525.html" rel="external">"Heart-lung transplantation in adults"</a>.)</p><p>The most common surgical approach for combined heart-lung transplantation is a bilateral thoracosternotomy (ie, clamshell) incision, although a sternotomy may be selected. The procedure is performed with full CPB, with the heart and lungs implanted en bloc.</p><p>Special considerations for anesthetic management of these patients include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Congenital heart disease</strong> – If an intracardiac shunt is present, a bubble-free technique for intravenous (IV) fluids and injection of drugs is critical to avoid cerebral air embolism. Worsening of right-to-left shunt from elevations in PVR during induction of anesthesia may cause hypoxia and is best treated by increasing systemic vascular resistance with vasopressors (<a class="drug drug_general" data-topicid="9709" href="/z/d/drug information/9709.html" rel="external">norepinephrine</a>, <a class="drug drug_general" data-topicid="10039" href="/z/d/drug information/10039.html" rel="external">vasopressin</a>, <a class="drug drug_general" data-topicid="9768" href="/z/d/drug information/9768.html" rel="external">phenylephrine</a>  (<a class="graphic graphic_table graphicRef119747" href="/z/d/graphic/119747.html" rel="external">table 3</a>)) and decreasing PVR by minimizing sympathetic stimulation and treating hypoxemia, hypercapnia, and acidosis. (See  <a class="medical medical_review" href="/z/d/html/99944.html" rel="external">"Anesthesia for adults with congenital heart disease undergoing noncardiac surgery", section on 'Precautions to avoid air embolism'</a> and  <a class="medical medical_review" href="/z/d/html/122847.html" rel="external">"Anesthesia for surgical repair of congenital heart defects in adults: Management of specific lesions and reoperation", section on 'Left-to-right shunt lesions'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pulmonary arterial hypertension with right ventricular failure</strong> – As noted above, patients with type 1 PAH are typically receiving chronically administered parental, oral, and inhaled PAH-targeted therapies  (<a class="graphic graphic_table graphicRef66348" href="/z/d/graphic/66348.html" rel="external">table 5</a>), which should be continued without interruption until CPB is initiated. (See <a class="local">'Chronically administered medications'</a> above.)</p><p></p><p class="headingAnchor" id="H1148476580"><span class="h2">Considerations during the COVID-19 pandemic</span><span class="headingEndMark"> — </span>The International Society of Heart and Lung Transplantation (ISHLT) advises that heart and lung transplantation proceed with caution during the coronavirus disease 2019 (COVID-19) pandemic, taking into account the potential risks of virus transmission, high mortality should COVID-19 develop in the recipient, and the loss of an opportunity for transplant should an available organ not be used [<a href="#rid33">33,34</a>]. Vaccination is strongly recommended for eligible children and adult transplant recipients along with anyone living with a transplant recipient. When possible, the vaccination series should be completed two weeks prior to transplant [<a href="#rid35">35</a>].</p><p>The ISHLT also advises that patients who contract COVID-19 while on the waitlist for lung transplantation should become inactive temporarily [<a href="#rid33">33</a>].<strong> </strong>Reactivation on the waitlist should await<strong> </strong>resolution of symptoms related to COVID-19 and two successive negative polymerase chain reaction (PCR) tests at least 24 to 48 hours apart.</p><p>If a transplant candidate has asymptomatic COVID-19, transplantation should be delayed for 14 days from diagnosis and after two successive negative PCR tests at least 24 to 48 hours apart.<strong> </strong>This timeframe is based on the higher acuity of heart and lung waitlisted patients and lesser opportunities for organ availability. (See  <a class="medical medical_review" href="/z/d/html/127582.html" rel="external">"COVID-19: Issues related to solid organ transplantation"</a>.)</p><p>Considerations for anesthetic and airway management of patients who might be shedding viral particles are discussed in a separate topic. (See  <a class="medical medical_review" href="/z/d/html/140910.html" rel="external">"Overview of infection control during anesthetic care", section on 'Considerations during aerosol-generating procedures'</a> and  <a class="medical medical_review" href="/z/d/html/140910.html" rel="external">"Overview of infection control during anesthetic care", section on 'Considerations with COVID-19 or other agents spread by aerosol'</a>.)</p><p class="headingAnchor" id="H102689968"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers patient education materials. "The Basics" patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients and families who want a general overview and who prefer short, easy-to-read materials. Here is the patient education article relevant to this topic (see  <a class="medical medical_basics" href="/z/d/html/87302.html" rel="external">"Patient education: Lung transplant (The Basics)"</a>). (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="headingAnchor" id="H3779579000"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Preoperative assessment</strong> – Preoperative assessment for lung transplantation focuses on (see <a class="local">'Preoperative assessment and communication'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Pulmonary status</strong> – Including etiology of respiratory failure, presence of pulmonary arterial hypertension (PAH), and preoperative oxygen requirements. (See <a class="local">'Assessment of pulmonary status'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Comorbidities</strong> – Includes determining whether the status of comorbidities has changed since the most recent review. (See <a class="local">'Assessment of comorbidities'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Communication</strong> – Includes discussion of the surgical team's planned approach (eg, single lung transplant, bilateral lung transplant, or heart-lung transplant) and planned use of mechanical cardiopulmonary support (eg, extracorporeal membrane oxygenation [ECMO], cardiopulmonary bypass [CPB]). (See <a class="local">'Communication regarding planned surgical approach'</a> above.)</p><p></p><p class="bulletIndent2">Some transplant centers find it helpful to have a checklist for preoperative review  (<a class="graphic graphic_table graphicRef106946" href="/z/d/graphic/106946.html" rel="external">table 1</a>).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Preparing for transfusion </strong>– We crossmatch four units of packed red blood cells (RBCs) and four units of fresh frozen plasma (FFP) for bilateral lung transplantation or single lung transplantation with planned mechanical cardiorespiratory support. Two units of RBCs are crossmatched for single lung transplantation. (See <a class="local">'Crossmatching for blood products'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Medication management</strong> – Chronically administered medications for chronic obstructive pulmonary disease (eg, bronchodilators) are continued throughout the perioperative period and for PAH (eg, pulmonary vasodilators) are continued in the preoperative and intraoperative periods, but are typically tapered and discontinued after reperfusion of the lung allograft(s). Premedication with a sedative is minimized and carefully titrated to avoid worsening hypercapnia and hypoxemia. (See <a class="local">'Preoperative medication management'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Analgesia</strong> – At our center, we usually use thoracic epidural analgesia (TEA) to control postoperative pain and reduce systemic opioid dosing. We place the catheter after reversal of anticoagulation to reduce risk for epidural hematoma. Other centers use a continuous paravertebral block (PVB). Even if a TEA or PVB catheter is placed preoperatively, dosing with local anesthetics during the intraoperative period is typically avoided to prevent sympathectomy-induced vasodilation and resultant hypotension. (See <a class="local">'Planning for postoperative analgesia'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Timing</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Minimize cold ischemic time</strong> – Donor lung procurement is carefully coordinated to minimize time from resection to implantation (cold ischemic time). Preoperative communication with the surgeon is necessary before transport of the patient to the operating room to establish that the donor lung has been assessed and is of sufficient quality. (See <a class="local">'Planning timing of anesthetic induction'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Fasting</strong> – Notification of a potential matched organ within hours of organ availability may not allow a preoperative fasting period adequate for stomach emptying  (<a class="graphic graphic_table graphicRef94641" href="/z/d/graphic/94641.html" rel="external">table 4</a>); thus, rapid sequence induction is frequently necessary. (See <a class="local">'Determination of fasting status'</a> above and  <a class="medical medical_review" href="/z/d/html/118937.html" rel="external">"Lung transplantation: Anesthetic management", section on 'Induction and intubation'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Special considerations</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>ECMO for respiratory failure</strong> – Patients with hypoxic or hypercarbic respiratory failure (eg, partial pressure of oxygen [PaO<sub>2</sub>] &lt;60 mmHg, partial pressure of carbon dioxide [PaCO<sub>2</sub>] &gt;60 mmHg, pH &lt;7.20) may benefit from preoperative initiation of venovenous (VV) ECMO as a bridge to transplantation  (<a class="graphic graphic_figure graphicRef56622" href="/z/d/graphic/56622.html" rel="external">figure 5</a> and <a class="graphic graphic_diagnosticimage graphicRef116518" href="/z/d/graphic/116518.html" rel="external">image 1</a>). The anesthesiology team typically assists with insertion of cannulae to initiate ECMO support using transesophageal echocardiography. (See <a class="local">'Preoperative extracorporeal membrane oxygenation'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>COVID-19</strong> – Patients who contract COVID-19 while waitlisted for lung transplantation typically become inactive on the waitlist until at least 14 days after initial diagnosis if asymptomatic, or until symptom resolution if symptomatic. In both cases, two successive negative polymerase chain reaction (PCR)-based tests should be documented 24 to 48 hours apart before the patient is reentered on the waitlist. Anesthetic and airway management of possibly infectious patients are discussed separately. (See <a class="local">'Considerations during the COVID-19 pandemic'</a> above and  <a class="medical medical_review" href="/z/d/html/127481.html" rel="external">"COVID-19: Perioperative risk assessment, preoperative screening and testing, and timing of surgery after infection"</a>.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Fessler J, Davignon M, Sage E, et al. Intraoperative Implications of the Recipients' Disease for Double-Lung Transplantation. J Cardiothorac Vasc Anesth 2021; 35:530.</a></li><li><a class="nounderline abstract_t">McGlothlin DP, Granton J, Klepetko W, et al. ISHLT consensus statement: Perioperative management of patients with pulmonary hypertension and right heart failure undergoing surgery. J Heart Lung Transplant 2022; 41:1135.</a></li><li><a class="nounderline abstract_t">Schisler T, Marquez JM, Hilmi I, Subramaniam K. Pulmonary Hypertensive Crisis on Induction of Anesthesia. Semin Cardiothorac Vasc Anesth 2017; 21:105.</a></li><li><a class="nounderline abstract_t">Moreno Garijo J, Cypel M, McRae K, et al. The Evolving Role of Extracorporeal Membrane Oxygenation in Lung Transplantation: Implications for Anesthetic Management. J Cardiothorac Vasc Anesth 2019; 33:1995.</a></li><li><a class="nounderline abstract_t">Weill D, Benden C, Corris PA, et al. A consensus document for the selection of lung transplant candidates: 2014--an update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2015; 34:1.</a></li><li><a class="nounderline abstract_t">Bottiger BA, Nicoara A, Snyder LD, et al. Frailty in the End-Stage Lung Disease or Heart Failure Patient: Implications for the Perioperative Transplant Clinician. J Cardiothorac Vasc Anesth 2019; 33:1382.</a></li><li><a class="nounderline abstract_t">Lee AJ, Huffmyer JL, Thiele EL, et al. The Changing Face of Cystic Fibrosis: An Update for Anesthesiologists. Anesth Analg 2022; 134:1245.</a></li><li><a class="nounderline abstract_t">Silhan LL, Shah PD, Chambers DC, et al. Lung transplantation in telomerase mutation carriers with pulmonary fibrosis. Eur Respir J 2014; 44:178.</a></li><li><a class="nounderline abstract_t">Martin AK, Renew JR, Jayaraman AL, et al. Analysis of Outcomes in Lung Transplantation. J Cardiothorac Vasc Anesth 2019; 33:1455.</a></li><li><a class="nounderline abstract_t">Cernak V, Oude Lansink-Hartgring A, van den Heuvel ER, et al. Incidence of Massive Transfusion and Overall Transfusion Requirements During Lung Transplantation Over a 25-Year Period. J Cardiothorac Vasc Anesth 2019; 33:2478.</a></li><li><a class="nounderline abstract_t">Huddleston SJ, Jackson S, Kane K, et al. Separate Effect of Perioperative Recombinant Human Factor VIIa Administration and Packed Red Blood Cell Transfusions on Midterm Survival in Lung Transplantation Recipients. J Cardiothorac Vasc Anesth 2020; 34:3013.</a></li><li><a class="nounderline abstract_t">Gelzinis TA. An Update on Postoperative Analgesia Following Lung Transplantation. J Cardiothorac Vasc Anesth 2018; 32:2662.</a></li><li><a class="nounderline abstract_t">McLean SR, von Homeyer P, Cheng A, et al. Assessing the Benefits of Preoperative Thoracic Epidural Placement for Lung Transplantation. J Cardiothorac Vasc Anesth 2018; 32:2654.</a></li><li><a class="nounderline abstract_t">Cason M, Naik A, Grimm JC, et al. The efficacy and safety of epidural-based analgesia in a case series of patients undergoing lung transplantation. J Cardiothorac Vasc Anesth 2015; 29:126.</a></li><li><a class="nounderline abstract_t">Pottecher J, Falcoz PE, Massard G, Dupeyron JP. Does thoracic epidural analgesia improve outcome after lung transplantation? Interact Cardiovasc Thorac Surg 2011; 12:51.</a></li><li><a class="nounderline abstract_t">Axtell AL, Heng EE, Fiedler AG, et al. Pain management and safety profiles after preoperative vs postoperative thoracic epidural insertion for bilateral lung transplantation. Clin Transplant 2018; 32:e13445.</a></li><li><a class="nounderline abstract_t">Yeung JH, Gates S, Naidu BV, et al. Paravertebral block versus thoracic epidural for patients undergoing thoracotomy. Cochrane Database Syst Rev 2016; 2:CD009121.</a></li><li><a class="nounderline abstract_t">Hutchins J, Apostolidou I, Shumway S, et al. Paravertebral Catheter Use for Postoperative Pain Control in Patients After Lung Transplant Surgery: A Prospective Observational Study. J Cardiothorac Vasc Anesth 2017; 31:142.</a></li><li><a class="nounderline abstract_t">Lenz N, Hirschburger M, Roehrig R, et al. Application of Continuous Wound-Infusion Catheters in Lung Transplantation: A Retrospective Data Analysis. Thorac Cardiovasc Surg 2017; 65:403.</a></li><li><a class="nounderline abstract_t">Hoopes CW, Kukreja J, Golden J, et al. Extracorporeal membrane oxygenation as a bridge to pulmonary transplantation. J Thorac Cardiovasc Surg 2013; 145:862.</a></li><li><a class="nounderline abstract_t">Hoetzenecker K, Donahoe L, Yeung JC, et al. Extracorporeal life support as a bridge to lung transplantation-experience of a high-volume transplant center. J Thorac Cardiovasc Surg 2018; 155:1316.</a></li><li><a class="nounderline abstract_t">Biscotti M, Gannon WD, Agerstrand C, et al. Awake Extracorporeal Membrane Oxygenation as Bridge to Lung Transplantation: A 9-Year Experience. Ann Thorac Surg 2017; 104:412.</a></li><li><a class="nounderline abstract_t">Hashimoto K, Hoetzenecker K, Yeung JC, et al. Intraoperative extracorporeal support during lung transplantation in patients bridged with venovenous extracorporeal membrane oxygenation. J Heart Lung Transplant 2018; 37:1418.</a></li><li><a class="nounderline abstract_t">Todd EM, Biswas Roy S, Hashimi AS, et al. Extracorporeal membrane oxygenation as a bridge to lung transplantation: A single-center experience in the present era. J Thorac Cardiovasc Surg 2017; 154:1798.</a></li><li><a class="nounderline abstract_t">Schechter MA, Ganapathi AM, Englum BR, et al. Spontaneously Breathing Extracorporeal Membrane Oxygenation Support Provides the Optimal Bridge to Lung Transplantation. Transplantation 2016; 100:2699.</a></li><li><a class="nounderline abstract_t">Fierro MA, Daneshmand MA, Bartz RR. Perioperative Management of the Adult Patient on Venovenous Extracorporeal Membrane Oxygenation Requiring Noncardiac Surgery. Anesthesiology 2018; 128:181.</a></li><li><a class="nounderline abstract_t">Martin AK, Yalamuri SM, Wilkey BJ, et al. The Impact of Anesthetic Management on Perioperative Outcomes in Lung Transplantation. J Cardiothorac Vasc Anesth 2020; 34:1669.</a></li><li><a class="nounderline abstract_t">Martin AK, Jayaraman AL, Nabzdyk CG, et al. Extracorporeal Membrane Oxygenation in Lung Transplantation: Analysis of Techniques and Outcomes. J Cardiothorac Vasc Anesth 2021; 35:644.</a></li><li><a class="nounderline abstract_t">Turner DA, Cheifetz IM, Rehder KJ, et al. Active rehabilitation and physical therapy during extracorporeal membrane oxygenation while awaiting lung transplantation: a practical approach. Crit Care Med 2011; 39:2593.</a></li><li><a class="nounderline abstract_t">Hakim AH, Ahmad U, McCurry KR, et al. Contemporary Outcomes of Extracorporeal Membrane Oxygenation Used as Bridge to Lung Transplantation. Ann Thorac Surg 2018; 106:192.</a></li><li><a class="nounderline abstract_t">Chambers DC, Yusen RD, Cherikh WS, et al. The Registry of the International Society for Heart and Lung Transplantation: Thirty-fourth Adult Lung And Heart-Lung Transplantation Report-2017; Focus Theme: Allograft ischemic time. J Heart Lung Transplant 2017; 36:1047.</a></li><li class="breakAll">Organ Procurement and Transplantation Network, National Data. Available at: https://optn.transplant.hrsa.gov/data/view-data-reports/national-data/# (Accessed on August 09, 2023).</li><li class="breakAll">Guidance from the International Society of Heart and Lung Transplantation regarding the SARS CoV-2 pandemic. https://ishlt.org/ishlt/media/documents/SARS-CoV-2_-Guidance-for-Cardiothoracic-Transplant-and-VAD-centers.pdf (Accessed on June 02, 2020).</li><li><a class="nounderline abstract_t">Loupy A, Aubert O, Reese PP, et al. Organ procurement and transplantation during the COVID-19 pandemic. Lancet 2020; 395:e95.</a></li><li class="breakAll">ISHLT/AST/ASTS Joint Statement About COVID-19 Vaccination in Organ Transplant Candidates and Recipients. The International Society for Heart and Lung Transplantation. https://ishlt.org/covid-19-information (Accessed on August 09, 2023).</li></ol></div><div id="topicVersionRevision">Topic 131415 Version 9.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32741611" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Intraoperative Implications of the Recipients' Disease for Double-Lung Transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36123001" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : ISHLT consensus statement: Perioperative management of patients with pulmonary hypertension and right heart failure undergoing surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27252226" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Pulmonary Hypertensive Crisis on Induction of Anesthesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30455142" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : The Evolving Role of Extracorporeal Membrane Oxygenation in Lung Transplantation: Implications for Anesthetic Management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25085497" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : A consensus document for the selection of lung transplant candidates: 2014--an update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30193783" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Frailty in the End-Stage Lung Disease or Heart Failure Patient: Implications for the Perioperative Transplant Clinician.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35020677" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : The Changing Face of Cystic Fibrosis: An Update for Anesthesiologists.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24833766" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Lung transplantation in telomerase mutation carriers with pulmonary fibrosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30072266" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Analysis of Outcomes in Lung Transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31147209" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Incidence of Massive Transfusion and Overall Transfusion Requirements During Lung Transplantation Over a 25-Year Period.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32718888" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Separate Effect of Perioperative Recombinant Human Factor VIIa Administration and Packed Red Blood Cell Transfusions on Midterm Survival in Lung Transplantation Recipients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29935804" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : An Update on Postoperative Analgesia Following Lung Transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29754733" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Assessing the Benefits of Preoperative Thoracic Epidural Placement for Lung Transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25440655" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : The efficacy and safety of epidural-based analgesia in a case series of patients undergoing lung transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20937664" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Does thoracic epidural analgesia improve outcome after lung transplantation?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30412311" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Pain management and safety profiles after preoperative vs postoperative thoracic epidural insertion for bilateral lung transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26897642" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Paravertebral block versus thoracic epidural for patients undergoing thoracotomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27543993" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Paravertebral Catheter Use for Postoperative Pain Control in Patients After Lung Transplant Surgery: A Prospective Observational Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27043787" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Application of Continuous Wound-Infusion Catheters in Lung Transplantation: A Retrospective Data Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23312979" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Extracorporeal membrane oxygenation as a bridge to pulmonary transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29248282" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Extracorporeal life support as a bridge to lung transplantation-experience of a high-volume transplant center.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28242078" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Awake Extracorporeal Membrane Oxygenation as Bridge to Lung Transplantation: A 9-Year Experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30193763" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Intraoperative extracorporeal support during lung transplantation in patients bridged with venovenous extracorporeal membrane oxygenation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29042051" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Extracorporeal membrane oxygenation as a bridge to lung transplantation: A single-center experience in the present era.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26910331" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Spontaneously Breathing Extracorporeal Membrane Oxygenation Support Provides the Optimal Bridge to Lung Transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28984630" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Perioperative Management of the Adult Patient on Venovenous Extracorporeal Membrane Oxygenation Requiring Noncardiac Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31623969" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : The Impact of Anesthetic Management on Perioperative Outcomes in Lung Transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32546408" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Extracorporeal Membrane Oxygenation in Lung Transplantation: Analysis of Techniques and Outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21765353" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Active rehabilitation and physical therapy during extracorporeal membrane oxygenation while awaiting lung transplantation: a practical approach.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29559375" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Contemporary Outcomes of Extracorporeal Membrane Oxygenation Used as Bridge to Lung Transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28784324" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : The Registry of the International Society for Heart and Lung Transplantation: Thirty-fourth Adult Lung And Heart-Lung Transplantation Report-2017; Focus Theme: Allograft ischemic time.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28784324" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : The Registry of the International Society for Heart and Lung Transplantation: Thirty-fourth Adult Lung And Heart-Lung Transplantation Report-2017; Focus Theme: Allograft ischemic time.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28784324" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : The Registry of the International Society for Heart and Lung Transplantation: Thirty-fourth Adult Lung And Heart-Lung Transplantation Report-2017; Focus Theme: Allograft ischemic time.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32407668" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Organ procurement and transplantation during the COVID-19 pandemic.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
